Lena Innala

1.2k total citations
11 papers, 630 citations indexed

About

Lena Innala is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Lena Innala has authored 11 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Hematology. Recurrent topics in Lena Innala's work include Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Lena Innala is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Lena Innala collaborates with scholars based in Sweden and United States. Lena Innala's co-authors include Solbritt Rantapää‐Dahlqvist, Torgny Smedby, Bozena Möller, Solveig Wållberg‐Jonsson, Staffan Magnusson, Heidi Kokkonen, Erik Jidell, Lotta Ljung, Anna Södergren and Ewa Berglin and has published in prestigious journals such as PLoS ONE, Arthritis Research & Therapy and The Journal of Rheumatology.

In The Last Decade

Lena Innala

11 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lena Innala Sweden 7 520 109 105 92 77 11 630
D. P. C. de Rooy Netherlands 12 441 0.8× 77 0.7× 77 0.7× 34 0.4× 80 1.0× 14 551
Jean‐Frédéric Boyer France 10 323 0.6× 52 0.5× 181 1.7× 64 0.7× 54 0.7× 15 553
L De Rycke Belgium 8 469 0.9× 215 2.0× 162 1.5× 34 0.4× 69 0.9× 15 610
D. van Schaardenburg Netherlands 9 628 1.2× 209 1.9× 178 1.7× 29 0.3× 149 1.9× 34 747
G. Lukina Russia 11 517 1.0× 115 1.1× 187 1.8× 43 0.5× 157 2.0× 94 633
Matt Cravets United States 11 330 0.6× 59 0.5× 106 1.0× 33 0.4× 157 2.0× 17 679
Kateryna Vostretsova Canada 5 378 0.7× 54 0.5× 231 2.2× 52 0.6× 32 0.4× 5 448
Bozena Möller Sweden 9 678 1.3× 69 0.6× 471 4.5× 104 1.1× 72 0.9× 12 962
Larissa Lisnevskaia Canada 6 505 1.0× 106 1.0× 394 3.8× 25 0.3× 47 0.6× 8 738
Miao Qi Australia 11 159 0.3× 77 0.7× 109 1.0× 65 0.7× 116 1.5× 27 452

Countries citing papers authored by Lena Innala

Since Specialization
Citations

This map shows the geographic impact of Lena Innala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Innala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Innala more than expected).

Fields of papers citing papers by Lena Innala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lena Innala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Innala. The network helps show where Lena Innala may publish in the future.

Co-authorship network of co-authors of Lena Innala

This figure shows the co-authorship network connecting the top 25 collaborators of Lena Innala. A scholar is included among the top collaborators of Lena Innala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Innala. Lena Innala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Innala, Lena, Staffan Magnusson, Bozena Möller, et al.. (2018). Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC/AHA Risk Calculator. The Journal of Rheumatology. 46(2). 130–137. 27 indexed citations
2.
3.
Innala, Lena, Clara Sjöberg, Bozena Möller, et al.. (2016). Co-morbidity in patients with early rheumatoid arthritis - inflammation matters. Arthritis Research & Therapy. 18(1). 33–33. 67 indexed citations
4.
Innala, Lena, Ewa Berglin, Bozena Möller, et al.. (2014). Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. Arthritis Research & Therapy. 16(2). R94–R94. 113 indexed citations
5.
Innala, Lena, Clara Sjöberg, Ewa Berglin, et al.. (2013). Comorbidity in early rheumatoid arthritis : does inflammation matter?. Arthritis & Rheumatism. 65. 1 indexed citations
6.
Innala, Lena, Bozena Möller, Lotta Ljung, et al.. (2012). Age at onset determines severity and choice of treatment in early rheumatoid arthritis. Arthritis & Rheumatism. 64(10). 1 indexed citations
7.
Innala, Lena, Bozena Möller, Lotta Ljung, et al.. (2011). Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Research & Therapy. 13(4). R131–R131. 186 indexed citations
8.
Innala, Lena, et al.. (2008). Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.. PubMed. 35(6). 1002–8. 84 indexed citations
9.
10.
11.
Innala, Lena, Heidi Kokkonen, Ewa Berglin, & Solbritt Rantapää‐Dahlqvist. (2006). Antibodies to mutated citrullinated vimentin (MCV) are a better predictor of disease activity at 24 months in rheumatoid arthritis than antibodies to cyclic citrullinated peptide (CCP).. Arthritis & Rheumatism. 54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. P. C. de Rooy Breakdown of academic impact, for papers by Jean‐Frédéric Boyer Breakdown of academic impact, for papers by L De Rycke Breakdown of academic impact, for papers by D. van Schaardenburg Breakdown of academic impact, for papers by G. Lukina Breakdown of academic impact, for papers by Matt Cravets Breakdown of academic impact, for papers by Kateryna Vostretsova Breakdown of academic impact, for papers by Bozena Möller Breakdown of academic impact, for papers by Larissa Lisnevskaia Breakdown of academic impact, for papers by Miao Qi
Rankless by CCL
2026